Aryl triazines as LPAAT-β inhibitors and uses thereof
US7618968B2 · kind B2 · utility
8Cited by
20References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2007 |
| Grant date | Nov 17, 2009 |
| Priority date | — |
| Expiry date | Aug 6, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to aryl triazines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity and/or proliferation of cells such as tumor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.